TITLE

A comparison of radiographic signs of pulmonary inflammation during ECMO between silicon and poly-methyl pentene oxygenators

AUTHOR(S)
Khoshbin, Espeed; Dux, Anthony E. W.; Killer, Hilliary; Sosnowski, Andrzej W.; Firmin, Richard K.; Peek, Giles J.
PUB. DATE
January 2007
SOURCE
Perfusion;Jan2007, Vol. 22 Issue 1, p15
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Introduction: The inflammatory response caused by extracorporeal membrane oxygenation (ECMO) is clearly visible within the first 24 h of cannulation. The inflammatory process affects all areas of the lung, even areas previously spared by the primary disease. Objective: To compare the change in the radiographic signs of inflammatory response to ECMO between poly-methyl pentene and silicon oxygenators. Study design: Retrospective review of neonates and adults pre- and post-replacement of silicon oxygenators with poly-methyl pentene devices. Data were collected from Extracorporeal Life Support Organisation (ELSO) registry forms and patient records. Results were analysed by quantitative and semi-quantitative methods. Results: There was a significant reduction in the radiographic signs of inflammatory response to ECMO, and a reduction in the time taken to revert to pre-ECMO state in the neonatal poly-methyl pentene group compared to silicon. However, there was no significant reduction in the duration of ECMO runs and the percentage survival between these groups in the neonates. In adults, there was no difference in severity of radiographic signs between groups. However, the inflammatory changes were relatively delayed in the adult poly-methyl pentene group. Conclusion: Polymethyl pentene (Medos) oxygenators have reduced the host's response phenomenon ‘white out’ in neonates, and caused a delayed response in adults. This is most likely a consequence of smaller blood contact surface area combined with the effect of heparin coating of the oxygenator membrane. However, recovery was not a function of the type of gas exchange device used.
ACCESSION #
25545891

 

Related Articles

  • Rat model of veno-arterial extracorporeal membrane oxygenation. Ali, Ayyaz A.; Downey, Peter; Singh, Gopal; Wei Qi; George, Isaac; Takayama, Hiroo; Kirtane, Ajay; Krishnan, Prakash; Zalewski, Adrian; Freed, Darren; Large, Stephen R.; Ashley, Euan A.; Leon, Martin B.; Bacchetta, Matthew; Ali, Ziad A. // Journal of Translational Medicine;2014, Vol. 12 Issue 1, p1 

    Background We aim to develop a rat model of veno-arterial extracorporeal membrane oxygenation (VAECMO). Methods VA-ECMO was established in twelve Male Sprague-Dawley rats (250-350 g) through cannulation of the right jugular vein for venous drainage and the right femoral artery for arterial...

  • Performance of polymethyl pentene oxygenators for neonatal extracorporeal membrane oxygenation: a comparison with silicone membrane oxygenators. Khoshbin, Espeed; Westrope, Claire; Pooboni, Suneel; Machin, David; Killer, Hilliary; Peek, Giles J.; Sosnowski, Andrzej W.; Firmin, Richard K. // Perfusion;May2005, Vol. 20 Issue 3, p129 

    Objective: To review the performance of polymethyl pentene versus silicone oxygenators in terms of efficiency in priming and oxygenation, oxygenator resistance, requirements for coagulation proteins and consumption of blood products, for neonatal extracorporeal membrane oxygenation (ECMO)...

  • Transcatheter closure of a patent arterial duct in a patient on veno-arterial extracorporeal membrane oxygenation. Brown, Kate L.; Shekerdemian, Lara S.; Penny, Daniel J. // Intensive Care Medicine;Apr2002, Vol. 28 Issue 4, p501 

    The presence of a patent arterial duct may complicate the course of the patient on veno-arterial extracorporeal membrane oxygenation (ECMO). While surgical ligation has been traditionally used as a definitive treatment for this problem, transcatheter closure may have advantages. This is the...

  • Extracorporeal Membrane Oxygenation: Quo Vadis? Betit, Peter // Respiratory Care;Jul2009, Vol. 54 Issue 7, p948 

    Extracorporeal membrane oxygenation, a form of artificial circulatory support, continues to evolve beyond its well-established neonatal applications. It is often the most aggressive aspect of treatment algorithms in the management of severe respiratory and cardiac failure. While its use is...

  • extracorporeal gas exchange. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p289 

    An encyclopedia entry for "extracorporeal gas exchange" is presented. The term refers to a method of diverting blood out of the body and through an artificial lung to assist respiration. The method involves extracorporeal membrane oxygenation (ECMO), a procedure wherein blood is passed over an...

  • The potential of accurate SVO2 monitoring during venovenous extracorporeal membrane oxygenation: an in vitro model using ultrasound dilution. Walker, Joshua; Primmer, Johanna; Searles, Bruce E.; Darling, Edward M. // Perfusion;Jul2007, Vol. 22 Issue 4, p239 

    Introduction. Some degree of recirculation occurs during venovenous extracorporeal membrane oxygenation (VV ECMO) which, (1) reduces oxygen (O2) delivery, and (2) renders venous line oxygen saturation monitoring unreliable as an index of perfusion adequacy. Ultrasound dilution allows clinicians...

  • Safety of recombinant factor VIIa in patients under extracorporeal membrane oxygenation. Anselmi, Amedeo; Guinet, Patrick; Ruggieri, Vito Giovanni; Aymami, Marie; Lelong, Bernard; Granry, Solène; Malledant, Yannick; Le Tulzo, Yves; Gueret, Pierre; Verhoye, Jean-Philippe; Flecher, Erwan // European Journal of Cardio-Thoracic Surgery;Jan2016, Vol. 49 Issue 1, p78 

    OBJECTIVES: To address the safety (rate of thromboembolic events and circuit complications) and efficacy (rate of bleeding control) of recombinant activated coagulation factor VII (rFVIIa) to treat severe bleeding refractory to all surgical and medical treatments in patients under veno-arterial...

  • Developmental outcome in newborn infants treated for acute respiratory failure with extracorporeal membrane oxygenation: present experience. Khambekar, K.; Nichani, S.; Luyt, D. K.; Peek, G.; Firmin, R. K.; Field, D. J.; Pandya, H. C. // Archives of Disease in Childhood -- Fetal & Neonatal Edition;Jan2006, Vol. 91 Issue 1, pF21 

    Objective: To describe the later health status of newborn infants who received extracorporeal membrane oxygenation (ECMO) for acute respiratory failure in the era after the UK ECMO trial. Design: Prospective follow up study of newborn infants who received ECMO at a single centre between January...

  • Compact intra- and extracorporeal oxygenator developments. Cattaneo, Giorgio; Strauß, Andreas; Reul, Helmut // Perfusion;Jul2004, Vol. 19 Issue 4, p251 

    For patients with acute lung failure, mechanical ventilation entails the risk of lung tissue damage due to high oxygen pressure and concentration. Membrane oxygenation for one to two weeks can rest the lungs due to decreased ventilation parameters, representing a potential bridge to recovery,...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics